Three-dimensional sonography with needle tracking: Role in diagnosis and treatment of prostate cancer

Journal of Ultrasound in Medicine

Volumn 27, Issue 6, 2008, Pages 895-905

  Shen, Feimo ^a,b,c,d,e   Shinohara, Katsuto ^a,b,c,d,e   Kumar, Dinesh ^a,b,c,d,e   Khemka, Animesh ^a,b,c,d,e   Simoneau, Anne R ^a,b,c,d,e   Werahera, Priya N ^a,b,c,d,e   Li, Lu ^a,b,c,d,e   Guo, Yujun ^a,b,c,d,e   Narayanan, Ramkrishnan ^a,b,c,d,e   Wei, Liyang ^a,b,c,d,e   Barqawi, Al ^a,b,c,d,e   Crawford, David ^a,b,c,d,e   Davatzikos, Christos ^a,b,c,d,e   Suri, Jasjit S ^a,b,c,d,e  

^a Eigen LLC   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF COLORADO   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

3 dimensional sonography; Diagnosis; Multi modality image fusion; Prostate cancer

Indexed keywords

BIOPSY; DIAGNOSIS; DISEASE CONTROL; IMAGE FUSION; MEDICAL IMAGING; NEEDLES; ULTRASONIC IMAGING; ULTRASONOGRAPHY; UROLOGY;

3-DIMENSIONAL SONOGRAPHY; CANCEROUS TISSUES; DISEASE DIAGNOSIS; MULTI-MODALITY IMAGE FUSION; NEEDLE NAVIGATIONS; PROBABILITY MAPS; PROSTATE CANCERS; TARGET IDENTIFICATION;

DISEASES;

ANATOMY; BIOCHEMISTRY; BIOPSY; CANCER DIAGNOSIS; CANCER THERAPY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DISEASE COURSE; ECHOGRAPHY; HUMAN; NEEDLE; NEEDLE TRACKING; PHYSIOLOGY; PROSTATE; PROSTATE CANCER; REVIEW; THREE DIMENSIONAL IMAGING;

EID: 46249107995     PISSN: 02784297     EISSN: None     Source Type: Journal    
DOI: 10.7863/jum.2008.27.6.895     Document Type: Review

References (47)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007; 57:43-66.
2. Lee F, Torp-Pedersen ST, McLeary RD. Diagnosis of prostate cancer by transrectal ultrasound. Urol Clin North Am 1989; 16:663-673.
3. American Cancer Society. Detailed guide: prostate cancer. http://www.cancer.Org/docroot/CRI/CRI_2_3x.asp?dt=36. Accessed November 12, 2007.
4. US Cancer Statistics Working Group. United States Cancer Statistics: 2003 Incidence and Mortality. Atlanta, GA: Department of Health and Human Services, Centers for Disease Control and Prevention, National Cancer Institute; 2007.
5. Gleason DF, Mellinger GT. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol 1974; 111:58-64.
6. Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG. AJCC Cancer Staging Manual. 6th ed. London, England: Springer; 2002.
7. Hodge KK, McNeal JE, Terris MK, Stamey TA. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 1989; 142:71-75.
8. Djavan B, Ravery V, Zlotta A, et al. Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop? J Urol 2001; 166:1679-1683.
9. Roehl KA, Antenor JA, Catalona WJ. Serial biopsy results in prostate cancer screening study. J Urol 2002; 167:2435-2439.
10. Stewart CS, Leibovich BC, Weaver AL, Lieber MM. Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. J Urol 2001; 166:86-92.
11. Zhan Y, Shen D, Zeng J, et al. Targeted prostate biopsy using statistical image analysis. IEEE Trans Med Imaging 2007; 26:779-788.
12. Swanson MG, Zektzer AS, Tabatabai ZL, et al. Quantitative analysis of prostate metabolites using 1H HR-MAS spectroscopy. Magn Reson Med 2006; 55:1257-1264.
13. Ophir J, Alam SK, Garra BS, et al. Elastography: imaging the elastic properties of soft tissues with ultrasound. J Med Ultrasonics 2002; 29:155-171.
14. Souchon R, Rouvière O, Gelet A, et al. Visualisation of HIFU lesions using elastography of the human prostate in vivo: preliminary results. Ultrasound Med Biol 2003; 29:1007-1015.
15. Elliot TL, Downey DB, Tong S, McLean CA, Fenster A. Accuracy of prostate volume measurements in vitro using three-dimensional ultrasound. Acad Radiol 1996; 3:401-406.
16. Tong S, Downey DB, Cardinal HN, Fenster A. A three-dimensional ultrasound prostate imaging system. Ultrasound Med Biol 1996; 22:735-746.
17. Barqawi AB, Li L, Crawford ED, Suri J. Semi-automated vs automated prostate boundary estimation from 3-D transrectal ultrasound images. Paper presented at: 2007 Computer-Assisted Radiology and Surgery Conference; 2007; Berlin, Germany.
18. Cool D, Downey D, Izawa J, Chin J, Fenster A. 3D prostate model formation from non-parallel 2D ultrasound biopsy images. Med Image Anal 2006; 10:875-887.
19. Kumar D, Shen D, Wei L, Turlapati R, Suri J. Motion correction strategies for interventional angiography images: a comparative approach. Paper presented at: IEEE International Conference on Imaging Processing; 2007; San Antonio, TX.
20. Wang Y, Cardinal HN, Downey DB, Fenster A. Semiautomatic three-dimensional segmentation of the prostate using two-dimensional ultrasound images. Med Phys 2003; 30:887-897.
21. Wei Z, Wan G, Gardi L, Mills G, Downey D, Fenster A. Robot-assisted 3D-TRUS guided prostate brachytherapy: system integration and validation. Med Phys 2004; 31:539-548.
22. Andriole GL, Williams ER. The utilization of ultrasound in the diagnosis of carcinoma of the prostate. In: US Genitourinary Disease. London, England: Touch Briefings; June 2006:28.
23. Taneja SS. Prostate biopsy: targeting cancer for detection and therapy. Rev Urol 2006; 8:173-182.
24. Park SB, Kim JK, Choi SH, Noh HN, Ji EK, Cho KS. Prostate volume measurement by TRUS using heights obtained by transaxial and midsagittal scanning: comparison with specimen volume following radical prostatectomy. Korean J Radiol 2000; 1:110-113.
25. Tong S, Cardinal HN, McLoughlin RF, Downey DB, Fenster A. Intra- and inter-observer variability and reliability of prostate volume measurement via two-dimensional and three-dimensional ultrasound imaging. Ultrasound Med Biol 1998; 24:673-681.
26. Chan T, Vese L. Active contours without edges. IEEE Trans Image Process 2001; 10:266-277.
27. Li C, Xu C, Gui C, Fox MD. Level set evolution without reinitialization: a new variational formulation. In: Proceedings of the IEEE International Conference on Computer Vision and Pattern Recognition. Piscataway, NJ: Institute of Electrical and Electronics Engineers; 2005:430-436.
28. Barqawi AB, Li L, Crawford ED, et al. Three Different Strategies for Real-Time Prostate Capsule Volume Computation from 3-D End-Fire Transrectal Ultrasound. Conf Proc IEEE Eng Med Biol Soc 2007; 2007:816-818.
29. Paul R, Schöler S, van Randenborgh H, et al. Optimization of prostatic biopsy: a prospective randomized trial comparing the sextant biopsy with a 10-core biopsy. Impact of prostatic region of sampling. Urol Int 2005; 74:203-208.
30. Naughton CK, Miller DC, Mager DE, Ornstein DK, Catalona WJ. A prospective randomized trial comparing 6 versus 12 prostate biopsy cores: impact on cancer detection. J Urol 2000; 164:388-392.
31. Chen ME, Troncoso P, Tang K, Babaian RJ, Johnston D. Comparison of prostate biopsy schemes by computer simulation. Urology 1999; 53:951-960.
32. Chen ME, Troncoso P, Johnston DA, Tang K, Babaian RJ. Optimization of prostate biopsy strategy using computer based analysis. J Urol 1997; 158:2168-2175.
33. Eskew LA, Bare RL, McCullough DL. Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J Urol 1997; 157:199-203.
34. Opell MB, Zeng J, Bauer JJ, et al. Investigating the distribution of prostate cancer using three-dimensional computer simulation. Prostate Cancer Prostatic Dis 2002; 5:204-208.
35. Zeng J, Bauer JJ, Mun SK. Modeling and mapping of prostate cancer. Comput Graph 2000; 24:683-694.
36. Xuan J, Wang Y, Sesterhenn IA, Moul JW, Mun SK. 3D model supported prostate biopsy simulation and evaluation. Notes Comput Sci 1998; 1496:358-367.
37. Frimmel H, Egevad L, Bengtsson E, Busch C. Modeling prostate cancer distributions. Urology 1999; 54:1028-1034.
38. Shen D, Lao Z, Zeng J, et al. Optimized prostate biopsy via a statistical atlas of cancer spatial distribution. Med Image Anal 2004; 8:139-150.
39. Schostak M, Schwall G, Poznanovic S, et al. Annexin A3 quantification from supernatants of urine after DRE provides a novel and clinically easy available biomarker for the non-invasive diagnosis of prostate cancer [abstract]. J Urol 2007; 177(suppl):470.
40. DiagnoCure. Prostate cancer diagnosis. http://www.diagnocure.com/en/ products-projects/prostate-cancer/prostate-cancer.php. Accessed September 1, 2007.
41. Meyerson M. Cancer: broken genes in solid tumours. Nature. 2007; 448:545-546.
42. Akin O, Hricak H. Imaging of prostate cancer. Radiol Clin North Am 2007; 45:207-222.
43. Yu KK, Hricak H. Imaging prostate cancer. Radiol Clin North Am 2000; 38:59-85, viii.
44. Moses WW, Huber J. Dedicated PET instrumentation for prostate imaging. Paper presented at: Advanced Molecular Imaging Techniques in the Detection, Diagnosis, Therapy, and Follow-up of Prostate Cancer; December 6-7, 2005; Rome, Italy.
45. Nucletron BV. Products & solutions. https://www.nucletron. com. Accessed November 11, 2007.
46. Varian Medical Systems. VariSeed. http://www.varian. com/us/oncology/ brachytherapy/variseed.html. Accessed November 11, 2007.
47. Medtronic Inc. About Medtronic Navigation: intra-operative imaging and navigation. http://www.medtronicnavigation. com/about. Accessed November 20, 2007.